Innovent presents preclinical data for IAR177 bispecific antibody
AI Summary- Innovent presented IAR177 preclinical data at ACR Convergence 2026.
- IAR177 targets IL-6 and TL1A through a single bispecific antibody.
- Innovent has launched 20 products and has one asset under NDA review.